
Heska Corporation (HSKA) Fundamental Analysis & Valuation
NASDAQ:HSKA • US42805E3062
Current stock price
119.99 USD
+0.05 (+0.04%)
At close:
119.99 USD
0 (0%)
After Hours:
This HSKA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HSKA Profitability Analysis
1.1 Basic Checks
- In the past year HSKA has reported negative net income.
- HSKA had a negative operating cash flow in the past year.
1.2 Ratios
- HSKA has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HSKA has a Gross Margin of 42.93%. This is in the lower half of the industry: HSKA underperforms 62.02% of its industry peers.
- HSKA's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for HSKA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.85%
2. HSKA Health Analysis
2.1 Basic Checks
- HSKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, HSKA has more shares outstanding
- The debt/assets ratio for HSKA has been reduced compared to a year ago.
2.2 Solvency
- HSKA has an Altman-Z score of 4.79. This indicates that HSKA is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of HSKA (4.79) is better than 75.48% of its industry peers.
- HSKA has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
- HSKA has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: HSKA outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.79 |
ROIC/WACCN/A
WACC9.05%
2.3 Liquidity
- A Current Ratio of 5.64 indicates that HSKA has no problem at all paying its short term obligations.
- With a decent Current ratio value of 5.64, HSKA is doing good in the industry, outperforming 70.67% of the companies in the same industry.
- HSKA has a Quick Ratio of 4.12. This indicates that HSKA is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 4.12, HSKA is in the better half of the industry, outperforming 68.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.64 | ||
| Quick Ratio | 4.12 |
3. HSKA Growth Analysis
3.1 Past
- The earnings per share for HSKA have decreased strongly by -51.97% in the last year.
- Looking at the last year, HSKA shows a decrease in Revenue. The Revenue has decreased by -1.22% in the last year.
- Measured over the past years, HSKA shows a quite strong growth in Revenue. The Revenue has been growing by 14.75% on average per year.
EPS 1Y (TTM)-51.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y28%
Revenue growth 5Y14.75%
Sales Q2Q%-3.73%
3.2 Future
- HSKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.44% yearly.
- The Revenue is expected to grow by 7.79% on average over the next years.
EPS Next Y55.25%
EPS Next 2Y40.17%
EPS Next 3Y27.58%
EPS Next 5Y26.44%
Revenue Next Year9.92%
Revenue Next 2Y9.98%
Revenue Next 3Y9.67%
Revenue Next 5Y7.79%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. HSKA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for HSKA. In the last year negative earnings were reported.
- Also next year HSKA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- HSKA's earnings are expected to grow with 27.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.17%
EPS Next 3Y27.58%
5. HSKA Dividend Analysis
5.1 Amount
- No dividends for HSKA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HSKA Fundamentals: All Metrics, Ratios and Statistics
119.99
+0.05 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-05 2023-05-05/bmo
Earnings (Next)08-07 2023-08-07/bmo
Inst Owners0.01%
Inst Owner Change0%
Ins Owners3.86%
Ins Owner Change0%
Market Cap1.31B
Revenue(TTM)254.89M
Net Income(TTM)-20.03M
Analysts78
Price Target132.6 (10.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-496.61%
Min EPS beat(2)-904.9%
Max EPS beat(2)-88.31%
EPS beat(4)1
Avg EPS beat(4)-332.9%
Min EPS beat(4)-904.9%
Max EPS beat(4)49.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.2%
Min Revenue beat(2)-4.99%
Max Revenue beat(2)0.58%
Revenue beat(4)1
Avg Revenue beat(4)-5.85%
Min Revenue beat(4)-11.47%
Max Revenue beat(4)0.58%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)22.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-233.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.14 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.14 | ||
| P/tB | 6.34 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.93
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS23.35
BVpS38.27
TBVpS18.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.93% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 25.03% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.64 | ||
| Quick Ratio | 4.12 | ||
| Altman-Z | 4.79 |
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)11.41%
Cap/Depr(5y)28.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y55.25%
EPS Next 2Y40.17%
EPS Next 3Y27.58%
EPS Next 5Y26.44%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y28%
Revenue growth 5Y14.75%
Sales Q2Q%-3.73%
Revenue Next Year9.92%
Revenue Next 2Y9.98%
Revenue Next 3Y9.67%
Revenue Next 5Y7.79%
EBIT growth 1Y-43.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.41%
EBIT Next 3Y72.39%
EBIT Next 5YN/A
FCF growth 1Y-461.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-344.65%
OCF growth 3YN/A
OCF growth 5YN/A
Heska Corporation / HSKA Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for Heska Corporation?
ChartMill assigns a fundamental rating of 3 / 10 to HSKA.
What is the valuation status of Heska Corporation (HSKA) stock?
ChartMill assigns a valuation rating of 1 / 10 to Heska Corporation (HSKA). This can be considered as Overvalued.
Can you provide the profitability details for Heska Corporation?
Heska Corporation (HSKA) has a profitability rating of 1 / 10.
How financially healthy is Heska Corporation?
The financial health rating of Heska Corporation (HSKA) is 7 / 10.
What is the expected EPS growth for Heska Corporation (HSKA) stock?
The Earnings per Share (EPS) of Heska Corporation (HSKA) is expected to grow by 55.25% in the next year.